| 71.69 Delayed Data As of 4:00pm ET |  -0.10 / -0.14%Today’s Change | 50.60 Today|||52-Week Range 97.38 | +25.77% Year-to-Date |
| Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)? Aug 08 / Zacks.com - Paid Partner Content |
| Previous close | 71.79 |
| Today’s open | 72.00 |
| Day’s range | 71.39 - 72.31 |
| Volume | 296,643 |
| Average volume (3 months) | 209,513 |
| Market cap | $3.7B |
| Earnings growth (last year) | -5.72% |
| Earnings growth (this year) | +6.96% |
| Earnings growth (next 5 years) | +11.50% |
| Revenue growth (last year) | +2.97% |
| P/E ratio | 62.3 |
| Price/Sales | 7.13 |
| Price/Book | 5.82 |
| Today’s change | Today’s % change | |
|---|---|---|
| QDELQuidel Corp | -0.28 | -0.45% |
| --Quidel Corp | 0.00 | 0.00% |
| MYGNMyriad Genetics Inc | -0.59 | -2.35% |
| VCYTVeracyte Inc | +0.61 | +2.42% |
| Next reporting date | September 23, 2019 |
| EPS forecast (this quarter) | $0.30 |
| Annual revenue (last year) | $414.2M |
| Annual profit (last year) | $60.2M |
| Net profit margin | 14.53% |
Sector Health Technology |
Industry Medical Specialties |
President & Chief Executive Officer John E. Adent |
Chief Financial Officer, Secretary & VP Steven James Quinlan |
Corporate headquarters Lansing, Michigan |
